NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD

[1]  M. Trauner,et al.  The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells , 2017, Hepatology.

[2]  Jonathan C. Cohen,et al.  Adiposity Amplifies the Genetic Risk of Fatty Liver Disease Conferred by Multiple Loci , 2017, Nature Genetics.

[3]  Inês Barroso,et al.  Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance , 2016, Nature Genetics.

[4]  Dermot F. Reilly,et al.  The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. , 2016, Gastroenterology.

[5]  Q. Anstee,et al.  The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2 , 2015, Seminars in Liver Disease.

[6]  V. Wong,et al.  PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease , 2015, Journal of gastroenterology and hepatology.

[7]  J. Dufour,et al.  Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. , 2014, Journal of hepatology.

[8]  K. Clément,et al.  TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease , 2014, Nature Communications.

[9]  K. Petersen,et al.  The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes , 2014, Nature.

[10]  E. Bugianesi,et al.  Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease , 2010, Hepatology.